Progressive supranuclear palsy (PSP) is a rare movement disorder with an estimated prevalence of 6.4 per 100,000, characterized by the accumulation of abnormally phosphorylated tau protein in the basal ganglia, frontal lobe and the brainstem [1]. Here, MAPT is linked to supranuclear palsy, progressive, 1.